Showing results (2411-2420 of 9,924) with videos related to
Sort By:
Pageof 993
Bone Marrow Transplantation|February 21, 2024
Prognostic factors in 448 newly diagnosed multiple myeloma receiving bortezomib-based induction: impact of ASCT, transplant refusal and high-risk MMHoi Ki Karen Tang, Chi Yeung Fung, Yu Yan Hwang, et al.Bone Marrow Transplantation|February 15, 2024
Peripheral blood stem cell transplantation using HLA-haploidentical donor with post-transplant cyclophosphamide versus HLA-matched sibling donor for lymphomaYosuke Nakaya, Hirohisa Nakamae, Masashi Nishikubo, et al.Bone Marrow Transplantation|November 7, 2023
AKI treated with kidney replacement therapy in critically Ill allogeneic hematopoietic stem cell transplant recipientsHelena Kim, Rafia Ali, Samuel Short, et al.Bone Marrow Transplantation|October 31, 2023
Post-transplantation cyclophosphamide is associated with increased bacterial infectionsCelalettin Ustun, Min Chen, Soyoung Kim, et al.Bone Marrow Transplantation|October 29, 2023
A novel approach to visualize clinical benefit of therapies for chronic graft versus host disease (cGvHD): the probability of being in response (PBR) applied to the REACH3 studyNorbert Hollaender, Ekkehard Glimm, Jennifer Gauvin, et al.Bone Marrow Transplantation|November 5, 2023
Treosulfan vs busulfan conditioning for allogeneic bmt in children with nonmalignant disease: a randomized phase 2 trialKarl-Walter Sykora, Rita Beier, Ansgar Schulz, et al.Bone Marrow Transplantation|July 13, 2023
External validation and extended application of the transplant conditioning intensity score in acute myeloid leukemiaMasamitsu Yanada, Yoshimitsu Shimomura, Shohei Mizuno, et al.Bone Marrow Transplantation|July 21, 2023
Trends in utilization of stored cryopreserved autologous peripheral hematopoietic cells intended for a second (or beyond) autologous hematopoietic cell transplantation in patients with multiple myeloma: a single center experienceFarah Yassine, Mohamed A Kharfan-Dabaja, Athanasios Tsalantsanis, et al.Bone Marrow Transplantation|August 5, 2023
Carfilzomib, lenalidomide and dexamethasone followed by a second ASCT is an effective strategy in first relapse multiple myeloma: a study on behalf of the Chronic malignancies working party of the EBMTRémi Tilmont, Ibrahim Yakoub-Agha, Diderik-Jan Eikema, et al.Bone Marrow Transplantation|August 8, 2023
Etoposide plus cytarabine versus cyclophosphamide or melphalan in busulfan-based preparative regimens for autologous stem cell transplantation in adults with acute myeloid leukemia in first complete remission: a study from the Acute Leukemia Working Party of the EBMTJaime Sanz, Myriam Labopin, Thomas Pabst, et al.Pageof 993